BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 28925574)

  • 1. Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.
    Takei R; Arita M; Kumagai S; Ito Y; Tokioka F; Koyama T; Saito R; Nishimura K; Tokumasu H; Ishida T
    Respirology; 2018 Apr; 23(4):385-391. PubMed ID: 28925574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
    Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
    BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
    Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
    J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.
    Tashkin DP; Volkmann ER; Tseng CH; Kim HJ; Goldin J; Clements P; Furst D; Khanna D; Kleerup E; Roth MD; Elashoff R
    Ann Rheum Dis; 2016 Feb; 75(2):374-81. PubMed ID: 25452309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary Fibrosis.
    Ryerson CJ; O'Connor D; Dunne JV; Schooley F; Hague CJ; Murphy D; Leipsic J; Wilcox PG
    Chest; 2015 Nov; 148(5):1268-1275. PubMed ID: 25996795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease.
    Solomon JJ; Chung JH; Cosgrove GP; Demoruelle MK; Fernandez-Perez ER; Fischer A; Frankel SK; Hobbs SB; Huie TJ; Ketzer J; Mannina A; Olson AL; Russell G; Tsuchiya Y; Yunt ZX; Zelarney PT; Brown KK; Swigris JJ
    Eur Respir J; 2016 Feb; 47(2):588-96. PubMed ID: 26585429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening of esophageal dilatation is associated with increase in a high-resolution computed tomography (HRCT) score in early systemic sclerosis-associated interstitial lung disease (SSc-ILD).
    Wangkaew S; Losuriya P; Euathrongchit J
    Clin Rheumatol; 2021 Mar; 40(3):955-963. PubMed ID: 32803568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
    Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
    Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease.
    Okamoto M; Fujimoto K; Sadohara J; Furuya K; Kaieda S; Miyamura T; Suematsu E; Kitasato Y; Kawayama T; Ida H; Ichiki M; Hoshino T
    Respir Investig; 2016 Nov; 54(6):445-453. PubMed ID: 27886856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease.
    Ito Y; Arita M; Kumagai S; Takei R; Noyama M; Tokioka F; Nishimura K; Koyama T; Tachibana H; Ishida T
    Mod Rheumatol; 2019 Jan; 29(1):98-104. PubMed ID: 29446698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oesophageal diameter is associated with severity but not progression of systemic sclerosis-associated interstitial lung disease.
    Winstone TA; Hague CJ; Soon J; Sulaiman N; Murphy D; Leipsic J; Dunne JV; Wilcox PG; Ryerson CJ
    Respirology; 2018 Oct; 23(10):921-926. PubMed ID: 29641847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
    Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
    PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD).
    Sieiro Santos C; Antolín SC; Lorenzo JC; Garay CL; Morales CM; de Miguel EB; Guerrero MR; Herránz LS; Álvarez ED
    Semin Arthritis Rheum; 2024 Apr; 65():152366. PubMed ID: 38290372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
    Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
    Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease.
    Chung JH; Walker CM; Hobbs S
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32744514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.